Abvance Therapeutics is developing an innovative solution to address unmet needs in diabetes care

Abvance has demonstrated pre-clinical proof of concept

Abvance is led by a strong team with deep drug development and metabolic expertise

Founders and Team

Alan Cherrington, PhD

Co-Founder and Inventor
Vanderbilt University

Aaron Davis

Commercial Consultant
Partner Jupiter Consulting
Former Vertex, Amylin

Soumitra Ghosh, PhD

Co-Founder, Drug Development Consultant
Former Amylin, BMS, MitoKor, Baxter

David Parkes, PhD

Pre-Clinical Pharmacology Consultant
Former Salk, Amylin, BMS, AZ, Profil, Gubra

Nimesh Shah

Business Operations Consultant
Former CBO Fractyl Labs,
Domain Associates, Alex Brown

Director

Will Clodfelter

Ponto Ventures
Former Medicus Biosciences, Amylin, Eli Lilly

Scientific Advisory Board

Bruce Bode, MD

Atlanta Diabetes Associates
Clinical Associate Professor, Emory University GA

Steve Edelman, MD

Professor of Medicine, UCSD
Founder Taking Control Of Your Diabetes

Jay Skyler, MD

Professor of Medicine
Division of Endocrinology Diabetes & Metabolism
University of Miami

John Buse, MD

Chief, Division of Endocrinology
University of North Carolina

David Maggs, MD

Becton Dickinson Technology Innovation
Former Fractyl Labs, Amylin, Pfizer, Parke Davis

Stephen Smith, MD

Chief Scientific Officer
AdventHealth Orlando Research Services

Strategic Partner

Contact Abvance Therapeutics – Aaron Davis – aaron@abvancetherapeutics.com